About Us

Webcasts & Presentations

Neurocrine Biosciences’s management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.

May 4, 2022

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2022 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) has scheduled its first quarter 2022 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on Wednesday, May 4, 2022.

Q1 2022 Corporate Presentation Link

OPEN WEBCAST

May 10, 2022

Neurocrine Biosciences to Present at the Bank of America Securities 2022 Healthcare Conference

Neurocrine Biosciences to Present at the Bank of America Securities 2022 Healthcare Conference
Kevin Gorman, Chief Executive Officer, and Matt Abernethy, Chief Financial Officer, Will Present at the Conference
Tuesday May 10, 2022 at 11:20 a.m. Pacific Time in Las Vegas

OPEN WEBCAST

Investors

For three decades, we have applied our unique insight into neuroscience to advance medicines for neurological, endocrine and psychiatric disorders. Our efforts have resulted in four FDA-approved therapies and a diverse, ambitious pipeline.

Learn More
Leadership Team

Our mission to relieve patient suffering begins with our leadership team. They lead our effort to relentlessly pursue medicines to ease the burden of debilitating diseases and disorders.

Learn More